Latest News

Journal Articles

Autoimmune

Could hyaluronic acid contribute to chronic white matter injury?

Can living in a sunnier climate in your youth reduce the risk of MS?

Could transcranial direct current stimulation offer relief from fatigue in multiple sclerosis sufferers?

Cerebrovascular disease

Blood pressure changes in mid-30s linked to poorer brain health

Age-related cognitive changes may be reduced with intensive blood pressure control

Hypertension drug increases cerebral blood flow in people with Alzheimer’s, study suggests

CNS/PNS/SNS

Nerve transfer surgery restores hand and arm function

EAN 2019: Neural clock and internal ‘GPS’ may provide valuable insights into Alzheimer’s disease

New technology generates synthetic speech using brain activity

Cognitive/neurodegenerative disorders

Blood pressure changes in mid-30s linked to poorer brain health

A first-in-human, gene-silencing treatment for Alzheimer’s disease with Catherine Mummery

Age-related cognitive changes may be reduced with intensive blood pressure control

Demyelinating disease

‘Smoldering’ spots: a hallmark for progressive multiple sclerosis?

Ponesimod hits key endpoints in clinical trial for relapsing multiple sclerosis: industry news round-up

Could MRI scans predict the disease progression of multiple sclerosis?

Development and pediatrics

A peek behind the paper – Melissa Bowerman on spinal muscular atrophy and the need for continued funding

Exosomes: the key to treating and diagnosing neurodevelopmental disorders?

Spinraza®: positive long-term data reported in pre-symptomatic infants

Epilepsy and seizure

Ponesimod hits key endpoints in clinical trial for relapsing multiple sclerosis: industry news round-up

WHO releases first global report on epilepsy

tRNAs: a blood-based biomarker for predicting seizures?

Genetics

A first-in-human, gene-silencing treatment for Alzheimer’s disease with Catherine Mummery

Advances in migraine genetics, neurobiology and treatment

Early-onset Alzheimer’s disease linked to high LDL cholesterol levels

Headache

Emgality® achieves primary and secondary outcomes in Phase III trial for migraines

Acute migraine: novel therapy shows promise in Phase III trial

Why are migraines more common in women? New sex-specific insights revealed

Immune disorders and inflammation

Inflammatory disease and anxiety: could endocannabinoids be a mechanism of comorbidity?

FENS 2018: Immune system offers new way of treating Alzheimer’s disease

FENS 2018: Could anxiety and inflammation be treated with cannabis?

Infection

Could a bacterial polysaccharide suppress fatal brain inflammation?

Link between Alzheimer’s disease and periodontal bacteria gains traction

ANA 2018: key highlights and news stories

Injury/trauma

Nerve transfer surgery restores hand and arm function

Can inflammatory biomarkers predict recovery time after concussion?

Signs of hidden consciousness detected after brain injury

Movement disorders

Study reveals the potential role of α-synuclein in DNA repair as a new target for Parkinson’s

Ponesimod hits key endpoints in clinical trial for relapsing multiple sclerosis: industry news round-up

A peek behind the paper – Sarah Hamm-Alvarez on oligomeric α-synuclein in basal tears of Parkinson’s patients

Neuro-ophthalmology

Gene therapy breakthrough allows mice to regain sight

Could an eye scan detect signs of Alzheimer's disease?

Vision in Alzheimer's disease: a focus on the anterior afferent pathway

Neurometabolic

Epigenetics, opioids and immune regulation: interviews from SfN17

Jeffrey Iliff: glymphatics, Alzheimer’s and future directions

SfN17: Neurodegeneration and the microbiome – new research highlights

Neuromuscular

Ataluren use in nonsense mutation Duchenne muscular dystrophy: patient information from the STRIDE Registry

New genetic suspects identified for ALS and FTD

Novel discovery in motor neuron disease may pave the way for future treatments

Neuropsychiatry

Could psychiatric disorders be triggered by air pollution?

Addiction: a compulsive interplay between drugs, cues and habits

Galanin identified as new therapeutic target for the treatment of depression

Oncology/tumor

Glioblastoma: could a blood test be on the horizon?

Veledimex: a drug-inducible gene therapy approach for glioblastoma yields promising Phase I results

Risk of Alzheimer’s may be raised by hormone therapy for prostate cancer

Pain

Emgality® achieves primary and secondary outcomes in Phase III trial for migraines

Advances in migraine genetics, neurobiology and treatment

Acute migraine: novel therapy shows promise in Phase III trial

Sleep

Acute light exposure at night doesn’t affect circadian rhythm in mice, research suggests

AAIC 2019: Sleep medications may increase dementia risk depending on race and gender

AAIC 2019: How can sleep disruption be improved in individuals with dementia?